about
A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Tenofovir in the management of chronic hepatitis B infection during pregnancyOccult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.Post-partum reactivation of chronic hepatitis B virus infection among hepatitis B e-antigen-negative women.Chronic hepatitis B in pregnancy: unique challenges and opportunitiesEvaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child TransmissionCase treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancyHBV perinatal transmissionLiver diseases in pregnancy: diseases not unique to pregnancy.SASLT practice guidelines for the management of hepatitis B virus.Evaluation of liver enzymes in asymptomatic chronic hepatitis B virus infected pregnant women.Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?Clinical course and management of acute and chronic viral hepatitis during pregnancy.Hepatitis B virus infection in children.Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model.Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Evaluation of hepatitis B virus transmission and antiviral therapy among hepatitis B surface antigen-positive pregnant women.Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.Effects of medical co-morbidities on severe maternal morbidities in China: a multicenter clinic register study.Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.
P2860
Q33711399-A3531FD8-0A46-4EC6-A1D4-7CD894A5CB65Q33973589-F515277D-EF13-4C9B-9C49-01F02456985AQ34947605-6ABFAE07-97E6-44A1-8E5D-8531A0571B30Q35012120-340479D0-B166-470B-BD31-2E7E00A5BAE1Q35833069-8384ECA8-6A5B-4240-BE7B-A9069CFAC962Q36182280-CA6D3FCB-8CA6-40B6-BE27-56126C195DB1Q36801132-A1924C6B-32EC-4E1B-92D0-7200FA33AA18Q36860696-B261DE8F-710E-4220-BE88-53FF8E89254CQ37334112-520C0D84-AC5C-40AF-8D48-F4206AADC174Q37634822-9BC75AB6-CB74-445A-BCDA-86C54F71395BQ37647638-CC88B9CF-F280-4951-9BE8-076EA03C2279Q38071401-5BBB74D3-A635-402E-A4C2-8EB5CEA05D28Q38257383-2CAE95A9-5CA2-470E-BE09-9DC0807AFBDDQ38365905-4928F1CA-3764-4126-A1AA-7A49D91D1D84Q38559455-6B6C71EE-DBED-4853-BD7B-724D7E442163Q38631865-63B65DA9-C2DB-4927-9015-B8BD51DEF102Q38692333-88F65324-A4DF-4DA1-9CA5-734D08C0FA9BQ40540669-5F639181-0E84-4425-B488-F1655287877EQ40950309-AEC286FA-5FE3-42DF-ACB3-270541E695F3Q41058355-4B433232-4D24-4B91-AF0E-C634BA9D0E7AQ45357942-00C5D518-5FBE-4BE4-B9E3-462DD9EE30EA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis B Therapy in Pregnancy
@ast
Hepatitis B Therapy in Pregnancy
@en
Hepatitis B Therapy in Pregnancy
@nl
type
label
Hepatitis B Therapy in Pregnancy
@ast
Hepatitis B Therapy in Pregnancy
@en
Hepatitis B Therapy in Pregnancy
@nl
prefLabel
Hepatitis B Therapy in Pregnancy
@ast
Hepatitis B Therapy in Pregnancy
@en
Hepatitis B Therapy in Pregnancy
@nl
P2860
P1476
Hepatitis B Therapy in Pregnancy
@en
P2093
Natalie H Bzowej
P2860
P304
P356
10.1007/S11901-010-0059-X
P577
2010-09-09T00:00:00Z